Another major reason why CBD oil has been positively received in some parts of the medical community is its apparent effect on cancer and tumor growth.A study done by the researchers of the Institute of Toxicology and Pharmacology, University of Rostock, Germany recommends the use of CBD oil (even direct injection into tumors) to eliminate or reduce the size of the tumors. The antioxidants in CBD hemp oil also provide anti-mutagenic properties and lower users’ risk of cancer.
All this talk about THC lands us nicely in the whole “Full Spectrum vs. Pure Isolate” debate. Once you begin shopping for CBD products, you’ll notice a lot of jargon that gets thrown around without much explanation. Now that we’ve introduced THC into the conversation, we can talk about the difference between, and relative benefits of, Full Spectrum CBD and CBD Isolate (and the lesser-known contender: Broad Spectrum).
Highly concentrated doses of CBD oil have been successfully used to treat epilepsy in a study conducted by Dr. Ian Rosemergy, Department of Neurology, Wellington Regional Hospital, Wellington, New Zealand. While there has been quite a limited success in medication to prevent or treat epilepsy, the physical and neurological regulatory properties of CBD oil represent an exciting new solution for people with this seizure-inducing condition.
Although anxiety disorders are generally treated with psychotherapy, medication, or a combination of the two, many people opt to forgo these standard approaches and self-treat with products like CBD oil. According to a survey published in Cannabis and Cannabinoid Research in 2018, almost 62 percent of cannabidiol users reported that they used CBD to treat a medical condition, with the top three conditions being pain, anxiety, and depression.
Hi Fred, thanks for your questions. I am not a doctor and this is not to be taken, interpreted or construed as medical advice. Please talk with a licensed medical professional about this. These are just my own personal thoughts and not a prescription or a diagnosis or any form of health care whatsoever.Here's a link to the kind we sell- you can order it online: BenGreenfieldFitness.com/cbd
CBD may help reduces REM behavior disorder in people with Parkinson’s disease. REM behavior disorder is a condition that causes people to act out physically during dreaming and REM sleep. Typically, during REM, the body is largely paralyzed, a state known as REM atonia. This immobilization keeps sleepers from reacting physically to their dreams. In REM behavior disorder, this paralysis doesn’t occur, leaving people free to move—which can lead to disruptive sleep and to injuring themselves or their sleeping partners. Cannabis may also work to reduce pain and improve sleep quality in people with Parkinson’s disease.
And then there’s cannabidiol (CBD), pictured right, which is one of at least 85 active cannabinoids identified in cannabis, but is a major part of the cannabis plant, accounting for up to 40% of the plant’s total cannabinoid extract. Due mostly to its safety and legality, CBD has long been researched for a much wider scope of medical applications than tetrahydrocannabinol (THC). We’ll get into the most relevant of those medical applications later.
5-HT1A agonist: 5-HT1A is a subtype of the serotonin receptor, which is important because anxiety and depression can sometimes be treated with medications that target the serotonin system. This is why drug companies developed selective serotonin reuptake inhibitors (SSRIs) like Prozac and Zoloft. SSRIs work by blocking reabsorption of serotonin in the brain, which increases availability of serotonin in the synaptic space. This helps brain cells transmit more serotonin signals, which can reduce anxiety and boost mood in certain cases (although the full biological basis for this is more complicated and not fully understood).
In 2005, Jen started sharing homemade dog treat recipes online. Using content and SEO best practices she grew that site to 87,500 visitors/month. Today, she blogs and does other things with words for small to mid-size businesses in industries as varied as pets and wellness. When not working with her fabulous clients, she’s often found reading a novel, practicing her Down Dog or cooking up a delicious meal. You can find out more at jenphillipsapril.com
Laboratory evidence indicated that cannabidiol may reduce THC clearance, increasing plasma concentrations which may raise THC availability to receptors and enhance its effect in a dose-dependent manner. In vitro, cannabidiol inhibited receptors affecting the activity of voltage-dependent sodium and potassium channels, which may affect neural activity. A small clinical trial reported that CBD partially inhibited the CYP2C-catalyzed hydroxylation of THC to 11-OH-THC.
When I first learned about CBD oil, I'll admit I was a bit skeptical. My mind immediately turned to weed and the unnerving experiences I'd had with heightened anxiety in college. For me, a person who's already predisposed to overthinking, marijuana, no matter what the form, would typically put my mind into overdrive and result in a common yet dreaded side effect: paranoia.
Cannabinoid therapy is connected to the part of the biological matrix where body and brain meet. Since CBD (cannabidiol) and other compounds in cannabis are so similar to the chemicals created by our own bodies, they are integrated better than many synthetic drugs. According to Bradley E. Alger, a leading scientist in the study of endocannabinoids with a PhD from Harvard in experimental psychology, “With complex actions in our immune system, nervous system, and virtually all of the body’s organs, the endocannabinoids are literally a bridge between body and mind. By understanding this system, we begin to see a mechanism that could connect brain activity and states of physical health and disease.”
In the United States, non-FDA approved CBD products are classified as Schedule I drugs under the Controlled Substances Act. This means that production, distribution, and possession of non-FDA approved CBD products is illegal under federal law. In addition, in 2016 the Drug Enforcement Administration added "marijuana extracts" to the list of Schedule I drugs, which it defined as "an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant." Previously, CBD had simply been considered "marijuana", which is a Schedule I drug.